These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9883804)

  • 1. Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes.
    Mundle SD; Ali A; Cartlidge JD; Reza S; Alvi S; Showel MM; Mativi BY; Shetty VT; Venugopal P; Gregory SA; Raza A
    Am J Hematol; 1999 Jan; 60(1):36-47. PubMed ID: 9883804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two in situ labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro.
    Mundle SD; Gao XZ; Khan S; Gregory SA; Preisler HD; Raza A
    Anticancer Res; 1995; 15(5B):1895-904. PubMed ID: 8572575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes.
    Mundle SD; Reza S; Ali A; Mativi Y; Shetty V; Venugopal P; Gregory SA; Raza A
    Cancer Lett; 1999 Jun; 140(1-2):201-7. PubMed ID: 10403560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
    Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
    Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
    Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY; Li X; Chang CK; Ying SX; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal antonymy unique to myelodysplastic marrows correlates with altered expression of E2F1.
    Mundle SD; Mativi BY; Cartlidge JD; Dangerfield B; Broady-Robinson L; Li B; Shetty V; Venugopal P; Gregory SA; Preisler HD; Raza A
    Br J Haematol; 2000 May; 109(2):376-81. PubMed ID: 10848828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes.
    Saberwal G; Broderick E; Janssen I; Shetty V; Alvi S; Lisak L; Venugopal P; Raza A; Mundle SD
    J Hematother Stem Cell Res; 2003 Aug; 12(4):443-50. PubMed ID: 12965081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.
    Mundle S; Venugopal P; Shetty V; Ali A; Chopra H; Handa H; Rose S; Mativi BY; Gregory SA; Preisler HD; Raza A
    Int J Hematol; 1999 Apr; 69(3):152-9. PubMed ID: 10222652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha induced DNA cleavage in human articular chondrocytes may involve multiple endonucleolytic activities during apoptosis.
    Fischer BA; Mundle S; Cole AA
    Microsc Res Tech; 2000 Aug; 50(3):236-42. PubMed ID: 10891889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes.
    Parcharidou A; Raza A; Economopoulos T; Papageorgiou E; Anagnostou D; Papadaki T; Raptis S
    Eur J Haematol; 1999 Jan; 62(1):19-26. PubMed ID: 9918307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow.
    Pecci A; Travaglino E; Klersy C; Invernizzi R
    Acta Haematol; 2003; 109(1):29-34. PubMed ID: 12486320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
    Wu L; Li X; Chang C; Ying S; He Q; Pu Q
    Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is apoptosis a massive process in myelodysplastic syndromes?
    Lepelley P; Campergue L; Grardel N; Preudhomme C; Cosson A; Fenaux P
    Br J Haematol; 1996 Nov; 95(2):368-71. PubMed ID: 8904894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes.
    Mundle SD; Venugopal P; Cartlidge JD; Pandav DV; Broady-Robinson L; Gezer S; Robin EL; Rifkin SR; Klein M; Alston DE; Hernandez BM; Rosi D; Alvi S; Shetty VT; Gregory SA; Raza A
    Blood; 1996 Oct; 88(7):2640-7. PubMed ID: 8839858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MCM2 in myelodysplastic syndromes: association with bone marrow cell apoptosis and peripheral cytopenia.
    Suzuki S; Kurata M; Abe S; Miyazawa R; Murayama T; Hidaka M; Yamamoto K; Kitagawa M
    Exp Mol Pathol; 2012 Feb; 92(1):160-6. PubMed ID: 22115939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.
    Kitagawa M; Yamaguchi S; Takahashi M; Tanizawa T; Hirokawa K; Kamiyama R
    Leukemia; 1998 Apr; 12(4):486-92. PubMed ID: 9557605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes.
    Peng H; Wen J; Zhang L; Li H; Chang CC; Zu Y; Zhou X
    Mol Biosyst; 2012 Apr; 8(4):1366-74. PubMed ID: 22327869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome.
    Flores-Figueroa E; Gutiérrez-Espíndola G; Montesinos JJ; Arana-Trejo RM; Mayani H
    Leuk Res; 2002 Jul; 26(7):677-86. PubMed ID: 12008086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.